• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Patchett Mary Sue was granted 3,901 shares, increasing direct ownership by 55% to 11,043 units (SEC Form 4)

    5/12/25 5:40:35 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Patchett Mary Sue

    (Last) (First) (Middle)
    300 GALLERIA PARKWAY SE, SUITE 800

    (Street)
    ATLANTA GA 30339

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Guardian Pharmacy Services, Inc. [ GRDN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/09/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 05/09/2025 A 3,901(1) A $0 11,043 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents restricted stock units payable solely in shares of Class A common stock of the Issuer.
    /s/ Douglas Towns, Attorney-in-Fact 05/12/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GRDN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    SEC Filings

    See more
    • SEC Form 8-K filed by Guardian Pharmacy Services Inc.

      8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

      5/12/25 4:25:41 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 10-Q filed by Guardian Pharmacy Services Inc.

      10-Q - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

      5/12/25 4:20:36 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

      5/12/25 4:16:12 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cosler Steven D was granted 3,901 shares, increasing direct ownership by 22% to 21,614 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      5/12/25 5:42:38 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Patchett Mary Sue was granted 3,901 shares, increasing direct ownership by 55% to 11,043 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      5/12/25 5:40:35 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Lewis Randall J was granted 3,901 shares, increasing direct ownership by 55% to 11,043 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      5/12/25 5:36:51 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    See more
    • Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

      5/8/25 4:05:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

      Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

      12/17/24 9:00:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

      Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

      10/21/24 8:25:47 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Truist initiated coverage on Guardian Pharmacy Services with a new price target

      Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

      10/21/24 7:42:42 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue of $329.3 million, an increase of 20% year-over-year, driven by organic growth and the previously announced acquisitions of Heartland Pharmacy on April 1, 2024 and Freedom Pharmacy on November 1, 2024 (the "acquisitions"). Resident Count of 189,000 at the end of the quarter, an increase of 15% year-over-year and up from 186,000 at December 31, 2024, attributable to organic growth and the acquisitions. Net Income of $9.3 million, an i

      5/12/25 4:05:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

      5/8/25 4:05:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days

      4/30/25 4:12:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      12/6/24 12:05:09 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      11/14/24 4:30:13 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      11/14/24 1:01:24 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    See more
    • Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days

      4/30/25 4:12:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245-3047 for U.S. participants, or (203) 518-9765 for international participants, and referencing conference ID "Guardian." A replay will be available shortly after the call's completion and remain available for approximately 60

      10/30/24 8:00:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      11/20/24 4:05:12 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      10/1/24 5:48:50 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Patchett Mary Sue bought $49,994 worth of shares (3,571 units at $14.00) and was granted 3,571 shares (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      10/1/24 5:46:36 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples